The Deshpande Center launches "The Technology to Improve Ability Program at MIT"
The Center will engage and encourage creative and ingenious minds across the MIT community to develop groundbreaking technologies to improve quality of life and autonomy for people living with disabilities, especially those with Down Syndrome. Teams of faculty, researchers and students will be invited to develop innovations that can become commercially available products. Grant funding and support will be available.
This program is made possible by a generous gift from the Alana Foundation and will be part of the Alana program at MIT
. A call for grant proposals will be announced in Sept 2019.
Via Separations closes a $4.8 million Series A financing round
Via Separations, a materials innovation company and Deshpande Center spin-out, announced the close of a $4.8 million Series A financing round with participation from Safar, PRIME Impact Fund, The Engine, Embark Ventures, and the Massachusetts Clean Energy Center.
Privo Technology, creates patch that can fight cancer
Privo Technologies, a Deshpande Center spin-out, has developed a patch to treat oral-cancel with localized chemotherapy, avoiding systemic side-effects and disfigurement from surgery. A chemotherapy drug is attached to nano-particles that are drawn into the cancer. Once inside the cancer, the drug is released killing the cancer.
A 3-D printer powered by machine vision and artificial intelligence
Inkbit, a startup out of Deshpande Center, is working to bring all of the benefits of 3-D printing to a slew of products that have never been printed before — and it’s aiming to do so at volumes that would radically disrupt production processes in a variety of industries.
Leuko Lab’s technology monitors white blood cell levels non-invasively, helping immunosuppressed and chemotherapy patients avoid infections and febrile neutropenia. Shining light into the skin surrounding the fingernail, Lekeuo’s device images the blood cells flowing through superficial capillaries to determine if white cell levels are dangerously low. There is no need to extract blood. Millions of immunosuppressed patients can now be tested more frequently, improving their quality of life and clinical outcomes.The company is a spin-out from the 2016 project, Non-invasive white cell count prototype
Amide Technologies have developed groundbreaking peptide synthesis by building instruments capable of delivering high-purity peptides quickly. Amide Technologies improves synthesis efficiency by combining flow chemistry with precision reagent and heating control during the reaction process. Purification is eliminated with this technology, reducing both time and cost for preparing peptides. This company is a spinout from a 2013 project, Fast Flow Peptides
Grant Project News
Congratulations to the IDEAS challenge winners!
Current Deshpande Center project team, lead by Professor Hadley Sikes and PhD candidate Eric Miller, won the MIT IDEAS grand prize of $15,000. Their research is focused on a urine-based test to cheaply and quickly diagnose tuberculosis in low-resource areas of India.
Eric Miller told MIT News, “If you’re living on $2 a day, you don’t necessarily have the financial freedom to travel to these clinics. We’re trying to replace that diagnostic with something that is decentralized, that can go to the patient.”
Our most recent IdeaStream program showcased presentations and posters in diagnostics, sensors, materials, water and therapeutics. Were you unable to attend this year? Check out videos from our current projects on our IdeaStream website on the "videos" tab.
Your Support of the Deshpande Center
Our grant programs are made possible by the support of many individuals. We could not accomplish our mission without your generosity. Thank you!
Your gifts help move technologies from the labs at MIT into the market, where they can have a positive impact on society. Your contribution educates researchers, supporting their research and educating them on the process of commercialization.